We propose to investigate the biochemical events that result in tumor specific elevated expression of the proto-oncogene MYC, which is found in the majority of adenocarcinomas of the large bowel. Our preliminary results demonstrate that COLON CANCER cells differ from other carcinomas in regulation of myc RNA abundance. Our investigation will lead to the definition of cellular regulatory mechanisms that differ between normal and neoplastic colonic epithelial cells. These studies will increase our understanding of GENETIC REGULATORY MECHANISMS in a cell type that has been relatively neglected in this regard. Also, in view of the fact that enhanced expression of c-myc has been shown to be a potentially oncogenic event, we may gain a deeper understanding of the regulatory alterations that underlie the neoplastic state. An increase in the abundance of a cellular macromolecule results from either increased BIOSYNTHESIS or decreased DEGRADATION. In order to determine the stage(s) of gene expression which is responsible for enhancing the level of myc RNA in malignant colon cells, we will analyze both synthesis (transcription) and stability of myc RNA in cell lines and patient samples, derived from normal colon and colorectal carcinoma. In further work on transcription of the myc gene, we will study chromatin structure, DNA binding proteins, and transcription factors. In further work on myc RNA stability, we will analyze RNA structure, RNA binding proteins, and factors involved in myc RNA degradation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA050246-02
Application #
3459498
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1989-08-02
Project End
1994-07-31
Budget Start
1990-08-01
Budget End
1991-07-31
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Missouri Kansas City
Department
Type
Schools of Medicine
DUNS #
800772162
City
Kansas City
State
MO
Country
United States
Zip Code
64110
Heruth, D P; Wetmore, L A; Leyva, A et al. (1995) Influence of protein tyrosine phosphorylation on the expression of the c-myc oncogene in cancer of the large bowel. J Cell Biochem 58:83-94
Rothberg, P G; Otto, Y M (1995) A polymorphic variant of human c-Myc: Asn11-->Ser. Mamm Genome 6:209-11
Gill Super, H J; Rothberg, P G; Kobayashi, H et al. (1994) Clonal, nonconstitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23. Blood 83:641-4
Bradley, J F; Rothberg, P G; Ladanyi, M et al. (1993) Hypermutation of the MYC gene in diffuse large cell lymphomas with translocations involving band 8q24. Genes Chromosomes Cancer 7:128-30
Heruth, D P; Zirnstein, G W; Bradley, J F et al. (1993) Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J Biol Chem 268:20466-72